807 results on '"Lobie, Peter E."'
Search Results
2. Biocompatible wearable touch panel based on ionically conductive organic hydrogels with anti-freezing, anti-dehydration, self-healing, and underwater adhesion properties
3. Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer
4. LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance
5. Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells
6. Optimizing adamantane derivatives for enhanced EGFR inhibition in MCF-7 breast cancer cells
7. Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer
8. Oxazine drug-seed induces paraptosis and apoptosis through reactive oxygen species/JNK pathway in human breast cancer cells
9. Pharmacodynamic and pharmacokinetic profiles of a novel GLP-1 receptor biased agonist-SAL0112
10. Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis
11. Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma
12. A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to β-catenin and suppressing the Wnt signaling pathway
13. Discovery of imidazopyridine-pyrazoline-hybrid structure as SHP-1 agonist that suppresses phospho-STAT3 signaling in human breast cancer cells
14. Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma
15. Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma.
16. Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma
17. Bead-jet printing enabled sparse mesenchymal stem cell patterning augments skeletal muscle and hair follicle regeneration
18. Mitochondria: The metabolic switch of cellular oncogenic transformation
19. The potential of long noncoding RNAs for precision medicine in human cancer
20. Synthesis of Tetrahydrocarbazole-Tethered Triazoles as Compounds Targeting Telomerase in Human Breast Cancer Cells.
21. An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity
22. A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib
23. Microfluidic Synthesis of Injectable Angiogenic Microgels
24. MAIT cell activation and recruitment in inflammation and tissue damage in acute appendicitis
25. Abstract A008: Pre-diabetic D-glucose exposure promotes EOC progression and cisplatin resistance: Role of BAD associated pathway and potential therapeutic strategy
26. Supplementary Figure S6 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion
27. Table S1 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion
28. Data from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion
29. Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma
30. Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression
31. Synthesis of C[sbnd]C, C[sbnd]N coupled novel substituted dibutyl benzothiazepinone derivatives and evaluation of their thrombin inhibitory activity
32. Development of novel indazolyl‐acyl hydrazones as antioxidant and anticancer agent that target VEGFR‐2 in human breast cancer cells
33. Synthesis of novel triazoles as anticancer agents targeting pJNK in human breast cancer cells
34. Converging neural-centric and mechano-regulation in organoid modeling for system biology and medicine
35. Development of Novel Pyridine and Pyrimidine Clubbed Bisindoles as Inhibitors of AKT Pathway.
36. Discovery of Piperazin‐2‐yl‐pyrimidines as Anticancer Agents via Targeting JNK Signaling Pathway in Human MCF‐7 Breast Carcinoma.
37. Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation
38. Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades
39. SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment
40. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis
41. Bad phosphorylation as a target of inhibition in oncology
42. The GDNF Family: A Role in Cancer?
43. Triple negative breast cancer in Asia: An insider’s view
44. Phenotypic Conversion of Human Mammary Carcinoma Cells by Autocrine Human Growth Hormone
45. Electrochemical Synthesis of Versatile Pyrimidine and Oxadiazoles Tethered Triazoles as Inhibitors of VEGFR-2 in Human Breast Cancer Cells
46. Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells
47. Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells
48. Tumour-Derived Human Growth Hormone As a Therapeutic Target in Oncology
49. EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
50. XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.